Anika Therapeutics Inc. (ANIK)
NASDAQ · Healthcare
Anika Therapeutics Inc. EBITDA 2009–2025
Anika Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Anika Therapeutics Inc. ebitda for the quarter ending March 31, 2026 was -4.1 M, a 40.68% increase year-over-year.
- Anika Therapeutics Inc. ebitda for the twelve months ending March 31, 2026 was -18.7 M, a 205.45% decrease year-over-year.
- Anika Therapeutics Inc. annual ebitda for 2025 was -5.7 M, a 418.51% decrease from 2024.
- Anika Therapeutics Inc. annual ebitda for 2024 was 1.8 M, a 75.50% decrease from 2023.
- Anika Therapeutics Inc. annual ebitda for 2023 was 7.3 M, a 29.84% decrease from 2022.
- Anika Therapeutics Inc. annual ebitda for 2022 was 10.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Anika Therapeutics Inc. EBITDA — FAQ
Anika Therapeutics Inc. (ANIK) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIK's ebitda history?
The chart and table above show Anika Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.